Terms: = Gastric cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Treatment
39 results:
1. Risk factors for death from other diseases after curative gastrectomy and lymph node dissection for gastric cancer.
Hanyu T; Ichikawa H; Kano Y; Ishikawa T; Muneoka Y; Hirose Y; Miura K; Tajima Y; Shimada Y; Sakata J; Wakai T
BMC Surg; 2024 Jan; 24(1):16. PubMed ID: 38191419
[TBL] [Abstract] [Full Text] [Related]
2. Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors.
Krishnan T; Safro M; Furlanetto DM; Gill S; Solar Vasconcelos JP; Stuart HC; Martineau P; Loree JM
J Neuroendocrinol; 2024 Jan; 36(1):e13360. PubMed ID: 38088132
[TBL] [Abstract] [Full Text] [Related]
3. Eosinophil may be a predictor of immune-related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study.
Tasaki Y; Sugiyama Y; Hamamoto S; Naiki T; Uemura T; Yokota K; Kawakita D; Nakamura M; Ogawa R; Shimura T; Mimura Y; Hotta Y; Odagiri K; Ito N; Iida M; Kimura Y; Komatsu H; Kataoka H; Takiguchi S; Morita A; Iwasaki S; Okuda K; Niimi A; Yasui T; Furukawa-Hibi Y
Cancer Med; 2023 Dec; 12(24):21666-21679. PubMed ID: 37986680
[TBL] [Abstract] [Full Text] [Related]
4. Development and external validation of a nomogram predicting overall survival for gastric adenocarcinoma patients with radical gastrectomy.
He Z; Lin F; Cheng T; Gao J; Wang H; Zhang Z; Deng X
Scand J Gastroenterol; 2024; 59(1):52-61. PubMed ID: 37632275
[TBL] [Abstract] [Full Text] [Related]
5. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors.
Liu Y; Mullangi S; Debono D; Chen X; Pham T; Fisch MJ; Gordon AS; Hershman DL
JCO Oncol Pract; 2023 Sep; 19(9):731-740. PubMed ID: 37384847
[TBL] [Abstract] [Full Text] [Related]
6. Nomogram-Based Prognostic Evaluation of gastric cancer Patients with Low Counts of Examined Lymph Nodes Outperforms the Predictive Ability of the 7
Sierzega M; Bobrzynski L; Kolodziejczyk P; Wallner G; Kulig J; Szczepanik A; ; Sierzega M; Bobrzynski L; Kolodziejczyk P; Wallner G; Kulig J; Szczepanik A; Dadan J; Drews M; Fraczek M; Jeziorski A; Krawczyk M; Starzynska T; Richter P
J Gastrointest Surg; 2023 Jan; 27(1):7-16. PubMed ID: 36138310
[TBL] [Abstract] [Full Text] [Related]
7. Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study.
Jiang Y; Zhang Z; Yuan Q; Wang W; Wang H; Li T; Huang W; Xie J; Chen C; Sun Z; Yu J; Xu Y; Poultsides GA; Xing L; Zhou Z; Li G; Li R
Lancet Digit Health; 2022 May; 4(5):e340-e350. PubMed ID: 35461691
[TBL] [Abstract] [Full Text] [Related]
8. IL-15-induced lymphocytes as adjuvant cellular immunotherapy for gastric cancer.
Hu Y; Liu D; Cui P; Zhang W; Chen H; Piao C; Lu Y; Liu X; Wang Y; Liu J; Lu X
Invest New Drugs; 2021 Dec; 39(6):1538-1548. PubMed ID: 34387808
[TBL] [Abstract] [Full Text] [Related]
9. LINC00668 cooperated with HuR dependent upregulation of PKN2 to facilitate gastric cancer metastasis.
Li J; Dong W; Jiang Q; Zhang F; Dong H
Cancer Biol Ther; 2021 Apr; 22(4):311-323. PubMed ID: 33879018
[TBL] [Abstract] [Full Text] [Related]
10. Comparisons of perioperative and survival outcomes of laparoscopic versus open gastrectomy for serosa-positive (pT4a) gastric cancer patients: a propensity score matched analysis.
Pang HY; Zhao LY; Zhang ZQ; Galiullin D; Chen XL; Liu K; Zhang WH; Yang K; Chen XZ; Hu JK
Langenbecks Arch Surg; 2021 May; 406(3):641-650. PubMed ID: 33825045
[TBL] [Abstract] [Full Text] [Related]
11. The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.
Méndez Romero A; Schillemans W; van Os R; Koppe F; Haasbeek CJ; Hendriksen EM; Muller K; Ceha HM; Braam PM; Reerink O; Intven MPM; Joye I; Jansen EPM; Westerveld H; Koedijk MS; Heijmen BJM; Buijsen J
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1377-1386. PubMed ID: 33451857
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of S-1-cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials.
Kawakami H; Fujitani K; Matsuyama J; Akamaru Y; Tamura S; Endo S; Kimura Y; Makari Y; Tamura T; Sugimoto N; Sakai D; Tsujinaka T; Goto M; Kurokawa Y; Shimokawa T; Satoh T;
Int J Clin Oncol; 2020 Sep; 25(9):1635-1643. PubMed ID: 32494981
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of lymph node metastasis in early gastric cancer: a single institutional experience from China.
Chen J; Zhao G; Wang Y
World J Surg Oncol; 2020 Mar; 18(1):57. PubMed ID: 32197625
[TBL] [Abstract] [Full Text] [Related]
14. TPK1 as a predictive marker for the anti-tumour effects of simvastatin in gastric cancer.
Hong JY; Kim HJ; Kim K; Hong J; Kim JE; Byeon SJ; Lee IK; Kim KM; Shim M; Park SH; Park JO; Park YS; Lim HY; Kim ST; Lee J; Kang WK
Pathol Res Pract; 2020 Mar; 216(3):152820. PubMed ID: 31964553
[TBL] [Abstract] [Full Text] [Related]
15. Identification of DNA methylation-regulated differentially-expressed genes and related pathways using Illumina 450K BeadChip and bioinformatic analysis in gastric cancer.
Liang Y; Zhang C; Dai DQ
Pathol Res Pract; 2019 Oct; 215(10):152570. PubMed ID: 31378454
[TBL] [Abstract] [Full Text] [Related]
16. GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer.
Park JE; Jin MH; Hur M; Nam AR; Bang JH; Won J; Oh DY; Bang YJ
Gastric Cancer; 2019 Sep; 22(5):932-940. PubMed ID: 30815759
[TBL] [Abstract] [Full Text] [Related]
17. A Novel Three-Step Approach for Secure Splenectomy During Laparoscopic Total Gastrectomy for gastric cancer.
Matsubara H; Kinjo Y; Fukugaki A; Iwamoto M; Ohara K; Ishino Y; Ochi S; Matsumoto T; Matsushita T; Satoh S
J Gastrointest Surg; 2019 May; 23(5):1082-1083. PubMed ID: 30367398
[TBL] [Abstract] [Full Text] [Related]
18. [Current status of diagnosis and treatment of early gastric cancer in China--Data from China Gastrointestinal cancer Surgery Union].
Wang Y; Li Z; Shan F; Miao R; Xue K; Li Z; Gao C; Chen N; Gao X; Li S; Ji J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):168-174. PubMed ID: 29492915
[TBL] [Abstract] [Full Text] [Related]
19. [Value of serum human epithelial growth factor receptor 2 extracellular domain and circulating tumor cells in evaluating therapeutic response in advanced gastric cancer].
Li Y; Peng Z; Zhang X; Gong J; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Nov; 20(11):1293-1299. PubMed ID: 29178102
[TBL] [Abstract] [Full Text] [Related]
20. MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating foxl2.
Yu L; Chen J; Liu Y; Zhang Z; Duan S
Cancer Biomark; 2017 Dec; 21(1):105-116. PubMed ID: 29060929
[TBL] [Abstract] [Full Text] [Related]
[Next]
